TLRY vs BUD vs SAM vs STZ

For growth investors, Tilray Brands, Inc.

(TLRY) is the stronger pick with 4. 8% revenue growth year-over-year, versus 0. 7% for Anheuser-Busch InBev SA/NV (BUD). The Boston Beer Company, Inc. (SAM) offers the better valuation at 20. 0x trailing P/E (20. 8x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, The Boston Beer Company, Inc.

(SAM) is the cheapest at 20. 0x versus Anheuser-Busch InBev SA/NV at 27. 9x. On forward P/E, Constellation Brands, Inc. is actually cheaper at 12. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Anheuser-Busch InBev SA/NV (BUD) delivered a total return of +13.

0%, compared to -82. 6% for The Boston Beer Company, Inc. (SAM). Over 10 years, the gap is even starker: SAM returned +28. 4% versus TLRY's -75. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Constellation Brands, Inc.

(STZ) is the lower-risk stock at 0. 28β versus Tilray Brands, Inc. 's 2. 04β — meaning TLRY is approximately 641% more volatile than STZ relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 170% for Constellation Brands, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Tilray Brands, Inc.

(TLRY) is pulling ahead at 4. 8% versus 0. 7% for Anheuser-Busch InBev SA/NV (BUD). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -651. 7% for Tilray Brands, Inc.. Over a 3-year CAGR, TLRY leads at 12. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Anheuser-Busch InBev SA/NV (BUD) is the more profitable company, earning 9.

8% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Constellation Brands, Inc.

(STZ) trades at 12. 5x forward P/E versus 20. 8x for The Boston Beer Company, Inc. — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TLRY: 79. 9% to $10. 00.

In this comparison, STZ (2.

7% yield), BUD (1. 6% yield) pay a dividend. TLRY, SAM do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Constellation Brands, Inc.

(STZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 28), 2. 7% yield). Tilray Brands, Inc. (TLRY) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (STZ: +11. 4%, TLRY: -75. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (TLRY (Healthcare) and BUD (Consumer Defensive) and SAM (Consumer Defensive) and STZ (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

BUD, STZ pay a dividend while TLRY, SAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.